Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes

Withdrawn before enrolling · Not applicable

Conditions studied: Diabetes

In brief

This study will test the hypothesis that oral repaglinide is equivalent to insulin in the treatment of new-onset CFRD in adolescents. In addition, successful treatment of CFRD with repaglinide will improve nutritional status, ameliorate declines in pulmonary function, and will not have a negative impact upon quality of life.

Key facts

Study ID

NCT00231192

Run by

Children's Hospital of Philadelphia

People needed

0

Starts

2005-10-01

Expected to finish

2007-08-01

Last updated by the study team

2015-03-12

Who can join

Age: 12 and older, up to 20. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Cystic Fibrosis, Blood glucose concerning for diabetes -

You may not qualify if…

• Known Cystic Fibrosis-Related Diabetes, Liver Disease, FEV1<40%

Where it is running

• The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.